PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts

INTRODUCTION: Alzheimer’s disease (AD) is indicated by a decrease in amyloid beta 42 (Aβ42) level or the Aβ42/Aβ40 ratio, and by increased levels of Tau with phosphorylated threonine at position 181 (pTau181) in cerebrospinal fluid (CSF) years before the onset of clinical symptoms. However, once onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Anna-Lena, Olm, Pauline, Utz, Janine, Siegmann, Eva-Maria, Spitzer, Philipp, Florvaag, Anna, Schmidt, Manuel Alexander, Doerfler, Arnd, Lewczuk, Piotr, Kornhuber, Johannes, Maler, Juan Manuel, Oberstein, Timo Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992803/
https://www.ncbi.nlm.nih.gov/pubmed/36909947
http://dx.doi.org/10.3389/fnagi.2023.1121500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992803/
https://www.ncbi.nlm.nih.gov/pubmed/36909947
http://dx.doi.org/10.3389/fnagi.2023.1121500

Ejemplares similares